Pressure Ulcer Prevention: a Turn and Positioning System Combined With Incontinence Care and Tailored/Standard Repositioning

Pressure Ulcers Clinical Trial

Official title:
A Turn and Positioning System and Standardized Incontinence Care Combined With Tailored Repositioning Versus a Standard Repositioning Protocol for Pressure Ulcer Prevention: A Multicenter Prospective Randomized Controlled Clinical Trial and Health Economical Analysis in a Hospital Setting

Status Completed

Clinical Trial Summary

The prevalence of pressure ulcer in hospitals is 7,3% - 23%. The primary etiological factors are pressure or pressure combined with shear. Prevention is very important and comprises: preventive skin care including cleansing and protecting the skin from exposure to moisture, the systematic repositioning of the patient, the offloading of the heels from the surface of the bed, the use of adequate bed support surfaces and an adequate nutritional status. The development and implementation of a risk based prevention plan for individuals identified as being at risk is strongly recommended. Limited compliance exists towards pressure ulcer preventive interventions. 25,5% of the patients at risk receive fully adequate prevention in bed. The reposition frequence is adequate in 55% of patients at risk. There is a lack of rigorously performed research addressing the effectiveness of devices or risk based protocols to improve compliance. Health care budgets are limited, priorities should be set in the allocation of health care resources.

The primary aim of this study is to compare the effectiveness of the turn and position system (Prevalon®Turn and Position System 2.0, SAGE) versus standard care to improve reposition frequence in patients at risk. The second aim is to compare the effectiveness of a tailored protocol versus standard care to improve reposition frequence in patients at risk. The third aim is to compare the effectiveness of standardized incontinence care versus standard care to improve the incidence of pressure ulcers and incontinence-associated dermatitis (IAD). Also a health economic evaluation will be performed.

The study will be performed in hospital setting (university and general hospitals) in a random sample of 226 patients aged > 18 who are at risk of developing pressure ulcers. Patients will be recruited from three types of wards: intensive care units, geriatric wards and rehabilitation wards. Patients will be included in the study for a period of 8 days.

Clinical Trial Description

n/a

Study Design

Related Conditions & MeSH terms

Dermatitis
Incontinence-associated Dermatitis
Pressure Ulcer
Pressure Ulcers
Ulcer

Clinical Trial Details

NCT number	NCT02690753
Study type	Interventional
Source	University Ghent
Contact
Status	Completed
Phase	N/A
Start date	February 2016
Completion date	December 2017

View Details

See also
Status	Clinical Trial	Phase
Completed	`NCT02930590` - Effects of Different Support Surfaces on the Properties Skin After Loading	N/A
Completed	`NCT02224404` - Post Market Clinical Follow-up Investigation to Evaluate Performance and Safety on Pressure Ulcers, PU, When Using Exufiber as Intended	N/A
Completed	`NCT01965444` - A Test of the Investigational SEM Scanner	N/A
Withdrawn	`NCT00623948` - Implanted Gluteal Stimulation System for Pressure Sore Prevention	N/A
Terminated	`NCT01433159` - Comparison of HP011-101 to Standard Care for Stage I-II Pressure Ulcers in Subjects With Spinal Cord Injury	Phase 2
Recruiting	`NCT01355666` - Silk-Like Fabric for the Prevention of Pressure Sores in a Long Term Care Setting	N/A
Completed	`NCT01403272` - Evaluate the Efficacy of a Silk-Like Fabric for the Prevention of Pressure Sores in a Long Term Care Setting	N/A
Completed	`NCT00971048` - Evaluation of the Effects of HP828-101 Versus Standard of Care in the Management of Partial or Full Thickness Wounds	N/A
Completed	`NCT01008254` - Interdisciplinary Mobility Approach To Reduction Of Facility-Acquired Pressure Ulcers	Phase 2/Phase 3
Terminated	`NCT00762138` - The AutoloGel™ Post-Market Surveillance (TAPS) Program	N/A
Completed	`NCT00507650` - Increasing Fluids in Older Adults to Prevent & Treat Pressure Ulcers	N/A
Completed	`NCT01877681` - Reference Nurse Program for Pressure Ulcers in Primary Care	Phase 2
Completed	`NCT01232764` - Pressure Ulcer Multi-disciplinary Teams Via Telemedicine (PUMTT): A Trial in Long Term Care	Phase 3
Completed	`NCT06374563` - Tackling Pressure Ulcer Via Bee Venom Phonophoresis	N/A
Completed	`NCT03070925` - Prospective PuraPly™ AM Case Series Study	N/A
Completed	`NCT02894437` - Qualitative Study of Preventive Organization of the Pelvic Bedsores Injured Spinal Cord
Completed	`NCT01348581` - Use of Fish Skin Extracellular Matrix (ECM) to Facilitate Chronic Wound Healing	N/A
Completed	`NCT00771238` - Pilot Study of Incidence and Change in Existing Pressure Ulcers: TC500 Bed Compared With Standard Beds	N/A
Completed	`NCT00763282` - Self-Management to Prevent Ulcers in Veterans With SCI (Spinal Cord Injury)	N/A
Completed	`NCT01885962` - Development and Feasibility of an Internet Intervention for Adults With Spinal Cord Injury to Prevent Pressure Ulcers	N/A

Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.